Press Release KIDZ AI Announces Expansion of Existing Share Repurchase Program by 50% to $3.0 Million Classover Holdings Inc. · Jul 28
Press Release Algo Grande Provides Phase II Drill Update at Adelita; Copper Intersected in Skarn and Andesitic Porphyry at Cerro Grande Algo Grande Copper Corp. · Jul 28
Press Release Advanced Bionics Announces FDA Approval of Expanded Cochlear Implant Inclusion Criteria for Patients with Single-Sided Deafness and Asymmetric Hearing Loss Advanced Bionics · Jul 28
Press Release Mission Inbox Acquires CeyMail to Fix Spam at the Source as AI Reshapes the Inbox Mission Inbox · Jul 28
Press Release The 20-Minute Payroll Myth: How Hemiton Global Eliminates the 11–13 Days of Hidden Payroll Work Issuewire · Jul 28
Press Release Trevi Therapeutics to Participate in Upcoming August Conferences Trevi Therapeutics, Inc. · Jul 28
Press Release Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O’Grady as Chief Executive Officer to Lead Strategic Growth Nasus Pharma, Ltd. · Jul 28
Press Release Palvella Therapeutics to Host Second Quarter 2026 Financial Results and Corporate Update Conference Call on August 4, 2026 Palvella Therapeutics Inc. · Jul 28
Press Release PMGC Holdings Inc. Announces Strategic Investment in Precision Aerospace & Defense Group and Long-Term Aerospace and Defense Manufacturing Agreement Through A&B Aerospace Inc. PMGC Holdings Inc. · Jul 28
Press Release Kiniksa Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Portfolio Execution Kiniksa Pharmaceuticals International, Plc · Jul 28
Press Release Kazia Therapeutics Announces the Filing of Provisional Patent for Novel Strategy, Supported by Preclinical Data, to Prevent Metastatic Recurrence in Triple-Negative Breast Cancer Kazia Therapeutics Ltd · Jul 28
Press Release ZenaTech’s ZenaDrone Begins Testing Phase for Interceptor P-1 Counter-UAS Drone Platform ZenaTech Inc. · Jul 28
Press Release Plus Therapeutics Announces Scientific Presentations and Sponsored Symposium at 2026 SNO/ASCO CNS Metastases Conference Plus Therapeutics Inc. · Jul 28